PolyActiva Commences Its First Phase I Clinical Trial with Potential to Improve Daily Lives of Millions of Glaucoma Patients Read more
Pfizer Terminates Domagrozumab (PF-06252616) Clinical Studies for the Treatment of Duchenne Muscular Dystrophy Read more
SunGen Pharma Establishes Injectable Division and Forms Manufacturing Relationship with GRAM Read more
REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease Read more
Indian Pharma Expo (IPE) 2018 held on 7th, 8th & 9th August 2018 at Pragati Maidan, New Delhi Read more
Medical, healthcare and MedTech innovations take centre stage at Asia’s leading exhibitions – MEDICAL FAIR ASIA & MEDICAL MANUFACTURING ASIA 2018 Read more